MTOR and gastric cancer: In vitro and in vivo experiments verified that LMOD1 could affect the migration ability of gastric cancer cells by regulating the FAK-Akt/mTOR pathway, which can alter the EMT of cells to promote the occurrence of peritoneal metastasis in gastric cancer (Fig. 6G).